Product Information

POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1296 per EA under NDC 00832532411. Its NADAC has been published 372 times since Jul 10, 2019.

FDA first approved this application on Nov 20, 1998. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 10 MEQ TABLET

potassium chloride
$0.1296per EA

Strength

750 mg/1

NDC

00832532411

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074726

FDA Approved

11/20/1998

TE Code

AB1

On Market Since

11/20/1998

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 372 times since Jul 10, 2019, and over the history we have for it it has declined 51.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1296 per EA
All-time high$0.3080 (Jan 15, 2020)
All-time low$0.0902 (Jul 17, 2024)
52-week high$0.1380
52-week low$0.1186
Median price$0.1698
Average price$0.1895
Largest weekly change+61.7% (Jun 19, 2024)
Weeks tracked372
Tracking sinceJul 10, 2019

Price History

1W

+1.2%

1M

+1.2%

3M

-6.1%

6M

-2.6%

1Y

-1.1%

3Y

-19.5%

5Y

-48.7%

All

-51.2%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1296 per EA (NDC 00832532411), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 51.2%. It has been tracked across 372 weekly CMS publications since Jul 10, 2019.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?

Since Jul 10, 2019, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0902 (Jul 17, 2024) to a high of $0.3080 (Jan 15, 2020), with a median of $0.1698 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ TABLET, is $0.0838 per EA — about 35% below POTASSIUM CL ER 10 MEQ TABLET.

Who manufactures POTASSIUM CL ER 10 MEQ TABLET?

POTASSIUM CL ER 10 MEQ TABLET (NDC 00832532411) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.